Anazaohealth
Anazaohealth (United States) has no DMF, CEP or site registration linked in our records. 11 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Anazaohealth: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/anazaohealth
Overview
Anazaohealth is a pharmaceutical company headquartered in Tampa, United States.
FDA compliance signals
11 FDA enforcement records linked to this company.
- 4832025-08-08
Absence of Written Procedures
- 4832025-08-08
Complaint Investigation/Follow-Up Findings
- 4832025-08-08
Procedures for sterile drug products
- 4832025-08-08
Complete test data included in records
- recall — Class II2024-01-03
Presence of Particulate Matter.
- recall — Class II2024-01-03
Presence of Particulate Matter.
- warning_letter2021-08-19
FDA Warning Letter (drug product)
- 4832019-09-19
Cleaning System
- 4832019-09-19
Product flow through building is inadequate
- warning_letter2015-12-09
FDA Warning Letter (drug product)
- recall — Class II2015-02-18
Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.
Is this Anazaohealth?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.